Skip to main content

Table 2 Patient sample characteristics (n = 314) for 3 MOA groups at Pretest (T2)

From: Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study

QLQ-C30

at pre-test (T2)

Paper & pencil at home

(n = 132)

Telephone

(n = 121)

Paper & pencil in-clinic

(n = 61)

 
 

Mean (s.d.)

%

floor/ceiling

Mean (s.d.)

%

floor/ceiling

Mean (s.d.)

%

floor/ceiling

Sig.

Physical function

62.0(28.9)

2%/23%

69.9(23.0)

2%/26%

66.8(24.2)

2%/23%

.052

Role function

59.2(31.3)

4%/27%

67.9(28.3)

5%/36%

66.9(28.6)

12%/35%

.050

Cognitive function*

80.0(18.4)

0%/43%

82.5(18.9)

1%/50%

87.2(14.4)

0%/39%

.038

Emotional function

74.4(21.0)

1%/20%

77.7(19.6)

1%/36%

78.6(18.7)

0%/26%

.294

Social function

76.5(27.6)

2%/52%

82.8(20.5)

1%/60%

81.7(22.7)

2%/51%

.103

GlobalHealth/QoL

61.5(22.0)

1%/6%

67.2(19.5)

1%/12%

66.1(19.6)

0%/8%

.078

Fatigue

45.6(26.0)

13%/3%

38.2(23.5)

21%/3%

40.1(26.9)

15%/3%

.060

Nausea/vomitig

14.1(21.3)

69%/1%

10.4(19.0)

76%/1%

13.4(18.5)

62%/2%

.321

Pain**

30.5(29.9)

30%/3%

24.7(26.2)

45%/4%

14.8(20.4)

46%/0%

.001

Dyspnea

20.1(27.9)

55%/4%

18.1(24.0)

55%/0%

18.0(24.0)

51%/2%

.785

Insomnia

30.0(33.8)

52%/8%

29.4(31.8)

63%/2%

21.9(28.5)

57%/3%

.226

Anorexia

24.2(29.8)

72%/2%

19.1(29.3)

72%/5%

22.2(29.9)

66%/2%

.392

Constipation

11.8(23.8)

83%/2%

7.8(19.2)

87%/1%

12.0(21.1)

82%/0%

.268

Diarrhea

10.8(21.7)

85%/1%

11.7(22.7)

85%/0%

4.4(13.0)

87%/0%

.074

Financial

8.2(19.0)

82%/1%

5.6(13.9)

89%/2%

3.3(11.7)

90%/0%

.117

  1. * p < 0.05 ** p < 0.01